Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.
K. Nishimura (Obu, Aichi, Japan), M. Kusunose (Obu, Aichi, Japan), R. Sanda (Obu, Aichi, Japan), M. Mori (Obu, Aichi, Japan), A. Shibayama (Obu, Aichi, Japan)
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Nishimura (Obu, Aichi, Japan), M. Kusunose (Obu, Aichi, Japan), R. Sanda (Obu, Aichi, Japan), M. Mori (Obu, Aichi, Japan), A. Shibayama (Obu, Aichi, Japan). Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.. 1595
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: